Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 1
2019 1
2020 3
2021 4
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kiyuri naicker (19 results)?
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates.
Karabasevic N, Roberts JA, Stronach L, Naicker S, Wallis SC, Sjövall F, Sime F. Karabasevic N, et al. Among authors: naicker s. Antimicrob Agents Chemother. 2022 May 17;66(5):e0214021. doi: 10.1128/aac.02140-21. Epub 2022 Apr 7. Antimicrob Agents Chemother. 2022. PMID: 35389238 Free PMC article.
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model.
Islam K, Sime FB, Wallis SC, Bauer MJ, Naicker S, Won H, Zowawi HM, Choudhury MA, Shirin T, Habib ZH, Harris PNA, Flora MS, Roberts JA. Islam K, et al. Among authors: naicker s. Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0016222. doi: 10.1128/aac.00162-22. Epub 2022 Aug 4. Antimicrob Agents Chemother. 2022. PMID: 35924928 Free PMC article.
Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase (ESBL)-producing versus non-ESBL-producing Escherichia coli in a hollow-fibre infection model.
Islam K, Sime FB, Bauer MJ, Forde BM, Wallis SC, Harris P, Naicker S, Shirin T, Habib ZH, Flora MS, Roberts JA. Islam K, et al. Among authors: naicker s. Int J Antimicrob Agents. 2022 Aug;60(2):106623. doi: 10.1016/j.ijantimicag.2022.106623. Epub 2022 Jun 18. Int J Antimicrob Agents. 2022. PMID: 35728714
16 results